Bipartisan congressional lawmakers have introduced a bill that would create a $75 million federal grant program to support research into the therapeutic potential of psychedelics for certain health conditions among active duty military service members.
Rep. Dan Crenshaw (R-TX) filed the legislation last week. It’s titled the “Douglas ‘Mike’ Day Psychedelic Therapy to Save Lives Act of 2023,” honoring a former Navy SEAL and Silver Star recipient who died in March.
The measure, which has 11 cosponsors and has been referred to the House Armed Services Committee, would direct the defense secretary to establish the grant program, funding phase two clinical trails into psilocybin, ibogaine, MDMA and 5–MeO–DMT, with a focus on exploring treatment applications for conditions including post-traumatic stress disorder, traumatic brain injury and chronic traumatic encephalopathy.
The grants could also be used to “train practitioners to provide treatment to members of the Armed Forces serving on active duty for covered conditions using covered psychedelic substances.”
The Defense Department would be appropriated $15 million each year from fiscal years 2024 to 2028 to support the grant program.
Entities that would be eligible for the grants include federal and state agencies, academic institutions and non-profit organizations.
The bill says that
Read full article on Marijuana Moment
